Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective

Archives of Internal Medicine

Volumn 161, Issue 10, 2001, Pages 1281-1288

  Strathdee, Steffanie A ^a   Galai, Noya ^b   Safaiean, Mahboobeh ^a   Celentano, David D ^a   Vlahov, David ^a,c   Johnson, Lisette ^a   Nelson, Kenrad E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COCAINE DEPENDENCE; EDUCATION; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEROCONVERSION; SEX DIFFERENCE;

EID: 0034927433     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.10.1281     Document Type: Article

References (50)

1. Trends in HIV incidence among young adults in the United States
2. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas
3. Injection drug use and human immunodeficiency virus infection: Injection drug use and human immunodeficiency virus infection
4. HIV-1 infection among intravenous drug users in Manhattan, New York City from 1977 through 1987
5. The ALIVE study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods
6. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users
7. Cocaine use and HIV infection in intravenous drug users in San Francisco
8. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1
9. High rates of HIV infection among injection drug users participating in needle exchange programs in Montréal: Results of a cohort study
10. Heterosexual transmission of human immunodeficiency virus among intravenous drug users
11. Large declines in sexual risk behavior with noncommercial partners among heterosexual injection drug users in Amsterdam, 1989-1995
12. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver
13. Risk factors for human immunodeficiency virus infection in intravenous drug users
14. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users
15. Sexual Behavior of drug injectors in London: Implications for HIV transmission and HIV prevention
16. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland
17. Temporal trends of incident HIV infection in a cohort of injection drug users in Baltimore, MD
18. Statistical methods in cancer research, II: The design and analysis of cohort studies
19. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users
20. Young and recent-onset injecting drug users are at higher risk for HIV
21. Correlates of HIV infection among young adult short-term injection drug users
22. Risk factors for shooting gallery use and cessation among intravenous drug users
23. H. risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico
24. Gender comparisons of injection drug use practices in shooting galleries
25. Syringe and needle exchange as HIV/AIDS prevention for injection drug users
26. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990
27. HIV incidence among injecting drug users in New York City syringe-exchange programmes
28. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up
29. Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV
30. Prevention of substance-related high-risk sexual behavior among gay men: Critical review of the literature and proposed harm reduction approach
31. Speed, sex, gay men, and HIV: Ecological and community perspectives
32. Social determinants predict needle sharing behaviour among injection drug users in Vancouver, Canada
33. HIV/AIDS among men who have sex with men and inject drugs - United States, 1985-1998
34. A multisite study of sexual orientation and injection drug use as predictors of HIV serostatus in out-of-treatment male drug users
35. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS
36. Female to male transmission of human immunodeficiency virus type 1: Risk factors for seroconversion in men
37. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics
38. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1
39. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection
40. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV
41. Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland
42. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users
43. HIV seroincidence among injection drug users in San Francisco, 1986 to 1998: Sexual transmission
44. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users
45. Assessing the validity of self-reported HIV risk behaviors collected by audio computer-assisted self-interview (ACASI) among a cohort of injection drug users (IDUs)
46. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high- and low-seroprevalence cities
47. HIV incidence among injecting drug users in New York City, 1992-1997: Evidence for a declining epidemic